Skip to main content
OpenTrials
Completed

NCT Number: NCT05201768

Determination of Walking, Balance, Fall Risk and Kinesiophobia in Individulas with Alzheimer's Dementation

THE OBJECTIVE OF THE RESEARCHERS IS TO DETERMINE WALKING, BALANCE, FALL RISK AND KINESIOPHOBIA IN INDIVIDUALS WITH ALZHEIMER'S DEMENTATION.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Kırıkkale University

Kirikkale, Turkey (Türkiye)

About this study

The gait, balance, fall risks and kinesiophobia of individuals with Alzheimer's Dementia will be evaluated and compared with healthy individuals.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • INDEPENDENT walker diagnosed with Alzheimer's Dementia

Exclusion criteria

  • Having a disability to do physical activity Those who have had an operation in the last 6 months

Treatment and study plan

balance tests,questionnaire

Other

Individuals will be tested and recorded.

Primary outcomes

  1. Age

    Time frame: 5 month

    between the ages of 50 and 80

  2. Body Mass Index

    Time frame: 5 month

    BMI was recorded in kg/m^2

Secondary outcomes

  1. The Tinetti Gait and Balance Test (TGBT)

    Time frame: 5 month

    TGBT consists of balance and gait subheadings. For balance, there are 13 items, and 9 items for gait. Items are scored as 0 (abnormal), 1 (adaptive) and 2 (normal) for balance, 0 (abnormal), 1 (normal) for gait. The maximum balance score of the patient is 26 and the maximum gait score is 9. Total score (balance + walking) is 35 points.

  2. Mini Mental State Test

    Time frame: 5 month

    It was used to determine the cognitive state before the training. The Mini-Mental State Test was first published by Folstein et al. It consists of eleven items under 5 main headings: orientation, record memory, attention and calculation, recall and language, and the total score is evaluated over 30 points.

  3. Tampa Scale

    Time frame: 5 month

    17 questions is a scale. The scale is used in work-related activities, injury/re-injury and fear-avoidance contains the parameters.

  4. The Time Up Go Test

    Time frame: 5 month

    The timed "Up & Go" measures, in seconds, the time taken by an individual to stand up from a standard arm chair (approximate seat height of 46 cm), walk a distance of 3 meters, turn, walk back to the chair, and sit down again.

  5. The Gait Speed Measurement Test (GSMT)

    Time frame: 5 month

    For GSMT, individuals were asked to walk at a speed they wanted on a flat surface of 14 m. Signs were placed on the 2nd and 12th meters of the test area to minimize the speed changes between walking start and walking finish, and to make a more objective measurement. The walking time at this 10-meter distance was measured with the stopwatch and the results were recorded in sec and the walking speed was determined.

  6. Fall Risk Self-Assessment Scale

    Time frame: 5 month

    It consists of 13 items assessing the risk of falling in the elderly. The answers are yes (1 point) and no (0 points), and individuals who get 4 points or more from the scoring are classified as having a high risk of falling.

Sponsors and collaborators

Lead sponsor

Kırıkkale University

Other

Registry information

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Jan 21, 2022
Registry last updated
Dec 3, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.